The changing pattern of bacterial sepsis since the introduction of antibiotic therapy

Insights

Sepsis incidence was 1 in 80 patients between 1968-1973. Improved preventative measures, early diagnosis, and vigorous treatment significantly lowered sepsis mortality rates.

Area of Science:

  • Infectious Diseases
  • Critical Care Medicine
  • Hospital Epidemiology

Background:

  • Sepsis represents a significant challenge in hospital settings, with varying incidence and mortality rates.
  • Gram-positive and Gram-negative organisms are primary causes of sepsis, each associated with distinct outcomes.
  • Previous mortality rates for sepsis, particularly urologic cases, were notably high.

Purpose of the Study:

  • To analyze the incidence and mortality rates of sepsis at a major hospital between 1968 and 1973.
  • To identify the causative pathogens (Gram-positive vs. Gram-negative) and their respective mortality.
  • To evaluate the impact of evolving medical interventions on sepsis outcomes.

Main Methods:

  • Retrospective analysis of patient data from Presbyterian Hospital, New York, spanning 1968-1973.
  • Categorization of sepsis cases by causative organism (Gram-positive, Gram-negative) and clinical source (urologic).
  • Comparison of mortality rates with historical data from 1959-1964.

Main Results:

  • Overall sepsis incidence was 1 in 80 patients.
  • Gram-positive sepsis occurred in 1 in 133 patients with a 4.4% mortality rate.
  • Gram-negative sepsis occurred in 1 in 188 patients with a 19.1% mortality rate; urologic sepsis had a 15.3% mortality rate.

Conclusions:

  • The study demonstrates a significant reduction in sepsis mortality compared to previous periods.
  • Effective sepsis management relies on a multi-faceted approach including prevention, early detection, and aggressive treatment.
  • Key therapeutic strategies involve correcting physiological derangements, timely antibiotic administration, and circulatory support.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...